GC
IBB icon

Garde Capital’s iShares Biotechnology ETF IBB Stock Holding History

Garde Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-279
Closed -$35.3K – 508
2025
Q2 		$35.3K Hold
279
– – ﹤0.01% 384
2025
Q1 		$35.7K Buy
+279
New +$37.8K ﹤0.01% 376
2022
Q3 		– Sell
-2,281
Closed -$268K – 246
2022
Q2 		$268K Sell
2,281
-892
-28% -$106K 0.03% 160
2022
Q1 		$413K Sell
3,173
-506
-14% -$65.9K 0.04% 139
2021
Q4 		$561K Sell
3,679
-55
-1% -$8.52K 0.05% 120
2021
Q3 		$604K Buy
3,734
+2,322
+164% +$391K 0.06% 113
2021
Q2 		$231K Hold
1,412
– – 0.02% 189
2021
Q1 		$213K Buy
1,412
+30
+2% +$4.76K 0.02% 184
2020
Q4 		$209K Buy
+1,382
New +$198K 0.03% 179

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Garde Capital's IBB Position: Q3 2025 in Review

Garde Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 279 shares — an estimated $35.3K sold.

Garde Capital first reported a position in IBB in Q4 2020 and held it in 9 quarters. The position peaked at $604K in Q3 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Garde Capital reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Garde Capital sold 279 iShares Biotechnology ETF shares in Q3 2025, an estimated $35.3K.
  • Garde Capital first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 9 quarters.
  • Garde Capital's iShares Biotechnology ETF position peaked at $604K in Q3 2021.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.